Alveolar cell carcinoma

Alveolar cell carcinoma (ACC), also known as adenocarcinoma of the lung, is a type of lung cancer that originates from the alveolar cells in the lungs. It is the most common type of lung cancer in non-smokers and is characterized by its slow growth and tendency to spread to the lymph nodes and other organs.

Etiology

The exact cause of alveolar cell carcinoma is unknown. However, several risk factors have been identified, including exposure to tobacco smoke, radon, asbestos, and certain carcinogens. Genetic factors may also play a role, as individuals with a family history of lung cancer are at a higher risk.

Symptoms

Symptoms of alveolar cell carcinoma can vary widely and may include persistent cough, chest pain, shortness of breath, fatigue, and unexplained weight loss. In some cases, the disease may be asymptomatic until it has advanced to a later stage.

Diagnosis

Diagnosis of alveolar cell carcinoma typically involves a combination of imaging tests, such as computed tomography (CT) scans and positron emission tomography (PET) scans, and tissue sampling procedures, such as bronchoscopy or biopsy.

Treatment

Treatment options for alveolar cell carcinoma depend on the stage of the disease and the patient's overall health. They may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these. In some cases, palliative care may be recommended to manage symptoms and improve quality of life.

Prognosis

The prognosis for alveolar cell carcinoma varies widely depending on the stage of the disease at diagnosis, the patient's overall health, and the effectiveness of treatment. Early detection and treatment can significantly improve survival rates.

See also

• Lung cancer
• Adenocarcinoma
• Carcinoma
• Alveoli